87 related articles for article (PubMed ID: 17546702)
1. Evaluation of tumor affinity of mono-[(123)I]iodohypericin and mono-[(123)I]iodoprotohypericin in a mouse model with a RIF-1 tumor.
Fonge H; Van de Putte M; Huyghe D; Bormans G; Ni Y; de Witte P; Verbruggen A
Contrast Media Mol Imaging; 2007; 2(3):113-9. PubMed ID: 17546702
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeled iodohypericin as tumor necrosis avid tracer: diagnostic and therapeutic potential.
Van de Putte M; Marysael T; Fonge H; Roskams T; Cona MM; Li J; Bormans G; Verbruggen A; Ni Y; de Witte PA
Int J Cancer; 2012 Jul; 131(2):E129-37. PubMed ID: 22038886
[TBL] [Abstract][Full Text] [Related]
3. Sequential systemic administrations of combretastatin A4 Phosphate and radioiodinated hypericin exert synergistic targeted theranostic effects with prolonged survival on SCID mice carrying bifocal tumor xenografts.
Li J; Cona MM; Chen F; Feng Y; Zhou L; Zhang G; Nuyts J; de Witte P; Zhang J; Yu J; Oyen R; Verbruggen A; Ni Y
Theranostics; 2013; 3(2):127-37. PubMed ID: 23423247
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model.
Chen B; Xu Y; Roskams T; Delaey E; Agostinis P; Vandenheede JR; de Witte P
Int J Cancer; 2001 Jul; 93(2):275-82. PubMed ID: 11410877
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and preliminary evaluation of mono-[123I]iodohypericin monocarboxylic acid as a necrosis avid imaging agent.
Fonge H; Jin L; Wang H; Ni Y; Bormans G; Verbruggen A
Bioorg Med Chem Lett; 2007 Jul; 17(14):4001-5. PubMed ID: 17507220
[TBL] [Abstract][Full Text] [Related]
6. Exploration of the mechanism underlying the tumor necrosis avidity of hypericin.
Van de Putte M; Ni Y; De Witte PA
Oncol Rep; 2008 Apr; 19(4):921-6. PubMed ID: 18357376
[TBL] [Abstract][Full Text] [Related]
7. Hypericin as a marker for determination of tissue viability after intratumoral ethanol injection in a murine liver tumor model.
Van de Putte M; Wang H; Chen F; de Witte PA; Ni Y
Acad Radiol; 2008 Jan; 15(1):107-13. PubMed ID: 18078913
[TBL] [Abstract][Full Text] [Related]
8. Elucidation of the tumoritropic principle of hypericin.
Van de Putte M; Roskams T; Vandenheede JR; Agostinis P; de Witte PA
Br J Cancer; 2005 Apr; 92(8):1406-13. PubMed ID: 15812555
[TBL] [Abstract][Full Text] [Related]
9. Targetability and biodistribution of radioiodinated hypericin: comparison between microdosing and carrier-added preparations.
Cona MM; Li J; Feng Y; Chen F; Verbruggen A; Witte Pd; Oyen R; Ni Y
Anticancer Agents Med Chem; 2014; 14(6):852-61. PubMed ID: 24102315
[TBL] [Abstract][Full Text] [Related]
10. First preclinical evaluation of mono-[123I]iodohypericin as a necrosis-avid tracer agent.
Ni Y; Huyghe D; Verbeke K; de Witte PA; Nuyts J; Mortelmans L; Chen F; Marchal G; Verbruggen AM; Bormans GM
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):595-601. PubMed ID: 16450141
[TBL] [Abstract][Full Text] [Related]
11. The impact of aggregation on the biodistribution of hypericin.
Van De Putte M; Roskams T; Bormans G; Verbruggen A; De Witte PA
Int J Oncol; 2006 Mar; 28(3):655-60. PubMed ID: 16465370
[TBL] [Abstract][Full Text] [Related]
12. Radionuclide imaging of tumor xenografts in mice using a gelatinase-targeting peptide.
Medina OP; Kairemo K; Valtanen H; Kangasniemi A; Kaukinen S; Ahonen I; Permi P; Annila A; Sneck M; Holopainen JM; Karonen SL; Kinnunen PK; Koivunen E
Anticancer Res; 2005; 25(1A):33-42. PubMed ID: 15816516
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of Tc-99m-labeled RRL-containing peptide as a non-invasive tumor imaging agent in a mouse fibrosarcoma model.
Kim DW; Kim WH; Kim MH; Kim CG
Ann Nucl Med; 2015 Nov; 29(9):779-85. PubMed ID: 26179963
[TBL] [Abstract][Full Text] [Related]
14. In situ 19F MRS measurement of RIF-1 tumor blood volume: corroboration by radioisotope-labeled [125I]-albumin and correlation to tumor size.
Baldwin NJ; Wang Y; Ng TC
Magn Reson Imaging; 1996; 14(3):275-80. PubMed ID: 8725193
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive detection and quantification of acute myocardial infarction in rabbits using mono-[123I]iodohypericin microSPECT.
Fonge H; Vunckx K; Wang H; Feng Y; Mortelmans L; Nuyts J; Bormans G; Verbruggen A; Ni Y
Eur Heart J; 2008 Jan; 29(2):260-9. PubMed ID: 18156139
[TBL] [Abstract][Full Text] [Related]
16. Scintigraphic imaging of the hypoxia marker (99m)technetium-labeled 2,2'-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (99mTc-labeled HL-91; prognox): noninvasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid.
Siim BG; Laux WT; Rutland MD; Palmer BN; Wilson WR
Cancer Res; 2000 Aug; 60(16):4582-8. PubMed ID: 10969810
[TBL] [Abstract][Full Text] [Related]
17. Histomorphological changes in murine fibrosarcoma after hypericin-based photodynamic therapy.
Bobrov N; Cavarga I; Longauer F; Rybárová S; Fedorocko P; Brezáni P; Miskovský P; Mirossay L; Stubna J
Phytomedicine; 2007 Feb; 14(2-3):172-8. PubMed ID: 17095201
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy of murine fibrosarcoma with topical and systemic administration of hypericin.
Cavarga I; Brezáni P; Cekanová-Figurová M; Solár P; Fedorocko P; Miskovský P
Phytomedicine; 2001 Sep; 8(5):325-30. PubMed ID: 11695874
[TBL] [Abstract][Full Text] [Related]
19. In vitro accumulation and permeation of hypericin and lipophilic analogues in 2-D and 3-D cellular systems.
Crnolatac I; Huygens A; Agostinis P; Kamuhabwa AR; Maes J; van Aerschot A; De Witte PA
Int J Oncol; 2007 Feb; 30(2):319-24. PubMed ID: 17203212
[TBL] [Abstract][Full Text] [Related]
20. Isolation and identification of fresh tumor-derived endothelial cells from a murine RIF-1 fibrosarcoma.
Modzelewski RA; Davies P; Watkins SC; Auerbach R; Chang MJ; Johnson CS
Cancer Res; 1994 Jan; 54(2):336-9. PubMed ID: 8275463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
